Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.
van de Borne P, Peeters A, Janssens L, Leone A, Lemmens R, Verhaegen A, De Meulemeester M, Balthazar Y, Heijmans S, Calozet Y, Paquot N, Carlier S, Hemelsoet D, Bray S, Ray KK.
van de Borne P, et al. Among authors: heijmans s.
Acta Cardiol. 2024 Feb;79(1):20-29. doi: 10.1080/00015385.2022.2030568. Epub 2022 Apr 20.
Acta Cardiol. 2024.
PMID: 35442151
Free article.